Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents
- 11 May 2010
- journal article
- case report
- Published by Wolters Kluwer Health in Circulation
- Vol. 121 (18) , 2067-2070
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Use of Indwelling Pleural Catheters for Chronic Pleural InfectionChest, 2008
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary InterventionCirculation, 2008
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCirculation, 2006
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive SummaryCirculation, 2006
- Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialThe Lancet, 2006
- Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and EchocardiographyAnnals of Internal Medicine, 2003
- The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular diseaseEuropean Heart Journal, 2000